No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Phase I: Adding carfilzomib to HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemia showed favourable safety and efficacy outcomes

byKathleen Lau

February 19, 2021

in StudyGraphics

RELATED REPORTS

Sacituzumab tirumotecan may have a role in the treatment of metastatic non-small cell lung cancer

#VisualAbstract: Avatrombopag is an Effective Treatment for Children and Adolescents with Immune Thrombocytopenia

2 Minute Medicine: Pharma Roundup – Perioperative Immunotherapy Efficacy, Expanded Prostate Cancer Indication, Rapid Subcutaneous Myeloma Administration, and Regulatory Compliance Findings [June 4 2025]

Bimekizumab shows better efficacy in treating severe plaque psoriasis than ustekinumab

RelatedReports

Lessons from real-world implementation of lung cancer screening

AI Roundup

Sacituzumab tirumotecan may have a role in the treatment of metastatic non-small cell lung cancer

June 10, 2025

StudyGraphics

#VisualAbstract: Avatrombopag is an Effective Treatment for Children and Adolescents with Immune Thrombocytopenia

June 9, 2025

Pharma

2 Minute Medicine: Pharma Roundup – Perioperative Immunotherapy Efficacy, Expanded Prostate Cancer Indication, Rapid Subcutaneous Myeloma Administration, and Regulatory Compliance Findings [June 4 2025]

June 4, 2025

New genetic link in pulmonary arterial hypertension holds therapeutic promise

Chronic Disease

Hereditary erythrocytosis is associated with a fetal-like EPO isoform

June 2, 2025

2 Minute Medicine Rewind February 22, 2021

Cancer to surpass heart disease as leading cause of death in the U.S. for higher-income persons

Early head-to-pelvis CT imaging for patients experiencing out-of-hospital circulatory arrest is safe and effective for determining causes of arrest

ACGME duty hour regulations linked with decreased perceived quality of care

Limiting On-Call Hours Improves Resident-Physicians’ Neurobehavioral Performance

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result